NEW YORK — MFB Fertility said on Wednesday that it has received US Food and Drug Administration clearance for its at-home progesterone ovulation test Proov.
According to the Boulder, Colorado-based company, Proov test strips are designed to measure the presence of PdG, a urine metabolite of the hormone progesterone. Tracking levels of PdG after suspected ovulation can confirm that ovulation has successfully occurred, MFB said.
The test was first launched in 2018.